Figure 1. Number of orphan drugs reimbursed in Belgium, 1999–2008.
Table 1. Overview of European orphan drug designations, 2000–2008.
Table 2. Characteristics of reimbursed orphan drugs in Belgium.
Table 3. Estimated budget impact of orphan drugs in Belgium in 2008.
Figure 2. Estimated budget impact of orphan drugs in Belgium, 2008–2013.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
